MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis

Experimental Hematology

Volumn 33, Issue 10, 2005, Pages 1192-1200

  Clutter, Suzanne D ^a   Fortney, James ^a   Gibson, Laura F ^a,b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ETOPOSIDE; GELATIN; GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR; RECOMBINANT PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; ASSAY; B LYMPHOCYTE; BONE MARROW CELL; CELL CULTURE; CELL MIGRATION; CHEMOTAXIS; CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRESS; STROMA CELL; SUPERNATANT; WESTERN BLOTTING; WILD TYPE; ZYMOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; B-LYMPHOCYTES; BONE MARROW CELLS; CHEMOKINES, CXC; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; ETOPOSIDE; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; PROTEIN BIOSYNTHESIS; RECEPTORS, CXCR4; STROMAL CELLS;

EID: 26244452730     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.06.022     Document Type: Article

References (36)

1. P.J. Hendrikx, C.M. Martens, A. Hagenbeek, J.F. Keij, and J.W. Visser Homing of fluorescently labeled murine hematopoietic stem cells Exp Hematol 24 1996 129 140
2. T. Papayannopoulou, and C. Craddock Homing and trafficking of hemopoietic progenitor cells Acta Haematol 97 1997 97 104
3. D.Y. Jo, S. Rafii, T. Hamada, and M.A. Moore Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1 J Clin Invest 105 2000 101 111
4. M. D'Apuzzo, A. Rolink, and M. Loetscher The chemokine CXCL12, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4 Eur J Immunol 27 1997 1788 1793
5. T. Nagasawa, S. Hirota, and K. Tachibana Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 Nature 382 1996 635 638
6. S. Janczewska, A. Ziolkowska, M. Durlik, E. Cybulska, W.L. Olszewski, and B. Lukomska Requirement of stromal cells in the bone marrow transplant for rapid lymphoid replenishment Transplant Proc 31 1999 696 699
7. E.S. Strobel, D. Mobest, and S. von Kleist Adhesion and migration are differentially regulated in hematopoietic progenitor cells by cytokines and extracellular matrix Blood 90 1997 3524 3532
8. A.J. Morris, J.E. Turnbull, G.P. Riley, M.Y. Gordon, and J.T. Gallagher Production of heparan sulphate proteoglycans by human bone marrow stromal cells J Cell Sci 99 Pt 1 1991 149 156
9. J.T. Gallagher, E. Spooncer, and T.M. Dexter Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures J Cell Sci 63 1983 155 171
10. Z. Drzeniek, B. Siebertz, and G. Stocker Proteoglycan synthesis in haematopoietic cells: isolation and characterization of heparan sulphate proteoglycans expressed by the bone-marrow stromal cell line MS-5 Biochem J 327 Pt 2 1997 473 480
11. R. Roberts, J. Gallagher, and E. Spooncer Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis Nature 332 1988 376 378
12. A. Amara, O. Lorthioir, and A. Valenzuela Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine J Biol Chem 274 1999 23916 23925
13. M. Verdrengh, and A. Tarkowski Impact of topoisomerase II inhibition on cytokine and chemokine production Inflamm Res 52 2003 148 153
14. M. Galotto, G. Berisso, and L. Delfino Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Exp Hematol 27 1999 1460 1466
15. W. Chamberlin, J. Barone, A. Kedo, and W. Fried Lack of recovery of murine hematopoietic stromal cells after irradiation-induced damage Blood 44 1974 385 392
16. L.F. Gibson, J. Fortney, K.S. Landreth, D. Piktel, S.G. Ericson, and J.P. Lynch Disruption of bone marrow stromal cell function by etoposide Biol Blood Marrow Transplant 3 1997 122 132
17. B.M. Hall, J.E. Fortney, and L.F. Gibson Alteration of nuclear factor-kappaB (NF-κB) expression in bone marrow stromal cells treated with etoposide Biochem Pharmacol 61 2001 1243 1252
18. B.M. Hall, J.E. Fortney, and L.F. Gibson Human bone marrow stromal cell CXCL12 production is reduced following exposure to topoisosmerase II inhibitors, etoposide or doxorubicin Analytical Pharmacology 4 2003 21 29
19. C. del Canizo, N. Lopez, and D. Caballero Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 23 1999 901 905
20. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 2001 463 516
21. L.A. Marquez-Curtis, A. Dobrowsky, and J. Montano Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures Br J Haematol 115 2001 595 604
22. A. Janowska-Wieczorek, A. Matsuzaki, and A. Marquez The hematopoietic microenvironment: matrix metalloproteinases in the hematopoietic microenvironment Hematology 4 2000 515 527
23. J. Fowlkes, K. Thrailkill, D. Serra, K. Suzuki, and H. Nagase Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases Progress in Growth Factor Research 6 1995 255 263
24. B. Heissig, K. Hattori, and S. Dias Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand Cell 109 2002 625 637
25. G.A. McQuibban, G.S. Butler, and J.H. Gong Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 J Biol Chem 276 2001 43503 43508
26. L.S. Collins, and K. Dorshkind A stromal cell line from myeloid long-term bone marrow cultures can support myelopoiesis and B lymphopoiesis J Immunol 138 1987 1082 1087
27. L.F. Gibson, D. Piktel, and K.S. Landreth Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells Blood 82 1993 3005 3011
28. D.B. Corry, K. Rishi, and J. Kanellis Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency Nat Immunol 3 2002 347 353
29. L. Wang, S. Clutter, J. Benincosa, J. Fortney, and L.F. Gibson Activation of TGFβ/p38/Smad3 signaling in stromal cells requires ROS-mediated MMP-2 activity during bone marrow damage Stem Cells 23 2005 93 102
30. I.W. Jeffrey, M. Bushell, V.J. Tilleray, S. Morley, and M.J. Clemens Inhibition of protein synthesis in apoptosis: differential requirements by the tumor necrosis factor alpha family and a DNA-damaging agent for caspases and the double-stranded RNA-dependent protein kinase Cancer Res 62 2002 2272 2280
31. J.M. Bradley, M.J. Kelley, A. Rose, and T.S. Acott Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch Invest Ophthalmol Vis Sci 44 2003 5174 5181
32. A.R. Tee, and C.G. Proud DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling Oncogene 19 2000 3021 3031
33. J. Esparza, M. Kruse, J. Lee, M. Michaud, and J.A. Madri MMP-2 null mice exhibit an early onset and severe experimental autoimmune encephalomyelitis due to an increase in MMP-9 expression and activity FASEB J 18 2004 1682 1691
34. D.B. Corry, A. Kiss, and L.Z. Song Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines FASEB J 18 2004 995 997
35. T. Itoh, H. Matsuda, M. Tanioka, K. Kuwabara, S. Itohara, and R. Suzuki The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis J Immunol 169 2002 2643 2647
36. B. Samolov, B. Steen, S. Seregard, I. van der Pleog, P. Montan, and A. Kvanta Delayed inflammation-associated corneal neovascularization in MMP-2 deficient mice Exp Eye Res 80 2005 159 166